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Background: The aim of our study was to assess the role of laser polarimetry and
visual evoked potentials (VEP) as potential biomarkers of disease progression in multiple
sclerosis (MS).
Participants:A total of 41 patients with MS (82 eyes) and 22 age-related healthy volunteers
(44 eyes) completed the study. MS patients were divided into two groups, one (ON) with
a history of optic neuritis (17 patients, 34 eyes) and another group (NON) without it (24
patients, 48 eyes).The MS patients and controls underwent laser polarimetry (GDx) exam-
ination of the retinal nerve fiber layer (RNFL). In the MS group, we also examined: Kurtzke
“expanded disability status scale” (EDSS), the duration of the disorder, VEP – latency and
amplitude, and conventional brain magnetic resonance imaging (MRI). Our results were
statistically analyzed using ANOVA, Mann–Whitney, and Spearman correlation analyses.
Results: In the MS group, brain atrophy and new T2 brain lesions in MRI correlated with
both VEP latencies and amplitudes. Separate comparisons revealed VEP latency testing to
be less sensitive in ON than in NON-patients. In ON patients, VEP amplitudes correlated
mildly with brain atrophy (r =−0.15) and strongly with brain new MRI lesions (r =−0.8).
In NON-patients, highly significant correlation of new MRI brain lesions with VEP latencies
(r =0.63, r =0.6) and amplitudes (r =−0.3, r =−4.2) was found. EDSS also correlated with
brain atrophy in this group (r =0.5). Our study did not find a correlation of GDx measures
with MRI tests. The GDx method was not able to detect whole brain demyelinization and
the degeneration process, but was only able to reveal the involvement of optic nerves in
ON and NON-patients.
Conclusion: In our study, we found that both methods (VEP and GDx) can be used for the
detection of optic nerve damage, butVEP was found to be superior in evaluating whole brain
demyelinization and axonal degeneration. Both VEP and MRI, but not GDx, have an impor-
tant role in monitoring disease progression in MS patients, independent of the ON history.
Keywords:VEP, laser polarimetry of optic nerve, MRI, multiple sclerosis, demyelinization and axonal degeneration
INTRODUCTION
Multiple sclerosis (MS) is characterized as a progressive inflam-
matory autoimmune disease of the central nervous system in
Abbreviations: EDSS= expanded disability status scale; GDx= laser polarimetry
with variable corneal compensation; MRI=magnetic resonance imaging; MRI
T1=T1-weighted imaging; MRI T2=T2-weighted imaging; MS=multiple scle-
rosis; MTR=magnetization transfer ratio; NFI= nerve fiber indicator; NON= no
history of optic neuritis; OCT= optic coherence tomography; ON= optic neu-
ritis; PD= proton density-weighted imaging; RNFL= retinal nerve fiber layer;
STIR= short T1 inversion recovery.
which axonal destruction occurs at early stages and is responsible
for the accumulation of irreversible disability (Kuhlmann et al.,
2002).
The proposed mechanisms of axonal degeneration in MS are
considered to vary depending on the stage of the disease. Dur-
ing the early stages of disorder, axonal injury correlates with the
magnitude of the inflammation. It has been proposed that in the
later stages, accumulation of tissue damage and loss of remyelina-
tion cause irreversible disability (Kuhlmann et al., 2002). Defining
the subclinical progression of the disorder is very challenging.
Standard clinical end points such as expanded disability status
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scale (EDSS) provide an indication of MS activity, but do not
always reveal early neurodegeneration changes. In recent years,
axonal damage and disease progression markers have been tested
for use in monitoring the early subclinical changes, since existing
methods have not been proved sensitive enough in evaluating the
disorder. In the future, short-lasting, highly available, and easy-
performed methods are expected to be available. In our study, we
focused on ophthalmological and electrophysiological tests. Scan-
ning laser polarimetry (GDx) with variable corneal compensation
(VCC) is a non-invasive imaging technique based on the pro-
jection of polarized near-infrared light and its retardation, when
propagating through a birefringent medium – i.e., retinal nerve
fiber layer (RNFL). It can detect changes resulting from axonal
cytoskeleton disorganization. GDx measures both the thickness
and integrity of RNFL. The potential of GDx to measure the
RNFL is considered to be comparable to that of optic coher-
ence tomography (OCT) (Zaveri et al., 2008; Galleta and Balcer,
2011).
Electrophysiological tests, including visual evoked potentials
(VEP), are among the newer approaches to examination that are
to be further investigated. Nowadays, they are considered to be
complementary to the clinical measurement of somatosensory
functions. VEP plays a useful role in the detection of early sub-
clinical changes of nerve tract demyelinization. It may have a role
similar to structural measures in detecting, and hence monitoring
the signs of early axonal destruction.
Here, we compare VEP and GDx with conventional magnetic
resonance imaging (MRI) to determine which of these markers is
most suitable to detect whole brain demyelinization and axonal
degeneration in MS.
SUBJECTS AND METHODS
PATIENTS
Patients with MS and disease-free patients (controls) participated
in the study of the visual function and the neuronal integrity of the
RNFL. MS patients were divided into two groups, one (ON) with
history of optic neuritis (17 patients, 34 eyes) and another group
(NON) without it (24 patients, 48 eyes). A total of 45 patients
with MS were recruited from patients treated in the MS Centre
at University Hospital in Martin, Slovakia. The inclusion criterion
for enrollment of ON patients was the history of optic neuritis
for at least 3 months prior to the date of study entry. Four of
them were excluded from the group: one patient had an ambly-
opic eye, three had moderate to severe loss of visual acuity and
difficulty concentrating during the ophthalmologic examination.
The remaining 17 ON patients were enrolled. NON-patients were
randomly selected from the patients of the MS centre. Out of the
enrolled MS patients, 90% (n= 37) had a relapse-remitting course
of the disorder, two had a secondary progressive course, and two
were diagnosed as having a clinically isolated syndrome. At the
time of the examination, the patients were undergoing treatment
by immunomodulatory agents (interferon beta, glatiramer acetate,
or intravenous methylprednisolone). These treatments complied
with the authorized recommendations for MS treatment in the
Slovak Republic. The mean length of treatment at the time of
entry into the study was 4.01± 2.8 years (p= 0.14 between ON
and NON).
The control group consisted of 22 age-related disease-free per-
sons with no history of visual problems and no evidence of
demyelinization disorder. Table 1 describes the demographic and
clinical characteristics of the patients.
CLINICAL AND PARACLINICAL EXAMINATIONS
Patients
Routine neurological and neurophysiological examinations were
performed on patients in the MS group. Complete visual function
tests were supplemented with GDx analysis. Optic neuritis was
confirmed by ophthalmological examination including a visual
acuity test, a color vision test, and fundoscopic examination of
the retina and the optic disk. Episodes of optic neuritis were
found to have occurred with the same frequency in both left and
right eyes.
The duration of disease was recorded in all participants. EDSS
and ophthalmology testing were performed at the same sessions.
Conventional MRI 1.5 T scans had been performed annually since
the date of diagnosis. At the time of study entry, new MRI scans
were performed to evaluate the range of brain atrophy. T2, T1,
Flair, and proton density-weighted imaging (PD-weighted images)
were used. The measurement of brain atrophy (level of neu-
rodegeneration) was performed with semi-automated radiological
protocol based on the manual segmentation technique. Semi-
automated edge detection contouring–thresholding technique was
manually corrected for the region of interest. The progression of
brain volume loss was detected after comparison with previously
measured values. Brain atrophy was determined longitudinally
by serial MRI in each individual patient. The final results were
affirmed by a radiologist either as positive (presence of brain
atrophy) or negative (brain atrophy not found). Comparison of
new T2 hyperintense lesions on follow-up scans with the baseline
measurements provided evidence for the intensity of inflamma-
tion. The presence of two or more new lesions in the current
T2-weighted MRI was interpreted as a positive sign of active
inflammation. MRI measurements were made at the same time
as VEP and GDx and evidence of lesions.
A Myoquick ISA 1800 EP from Micromed was used for VEP
P100 waves examination. Latency and amplitude of P100 waves
were individually judged.
Table 1 | Demographic and clinical characteristics of the patients.
ON NON Controls
Patients/eyes 17/34 24/48 22/44
Females 14 14 17
Age 34.0±10.6 37.6±9.3° 39.8±11.5°°
Disease duration 6.5±1.1 5.8±0.96* –
EDSS 2.6±1.1 2.4±1.1 –
° The difference between ON and NON-groups p= 0.16.
°° The difference between Con and MS p=0.12.
*The difference between groups p=0.33 (p=0.05 statistical significance),
ANOVA test.
ON=patients with history of ON, NON=patients without history of ON.
EDSS=expanded disability status scale.
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The control group of 22 age-related disease-free subjects
underwent ophthalmological tests.
RETINAL NERVE FIBER LAYER MEASUREMENT
Patients with MS and controls underwent measurement of the
RNFL thickness for both eyes using GDx with VCC (software
version 5.5.1, 2005 Carl Zeiss Meditec). These scans were cen-
tered on the optic disk using a scan circle of 3.2 mm; the mean of
three separate measurements was used. The temporal–superior–
nasal–inferior–temporal average RNFL thickness was used as the
summary parameter for GDx. RNFL pathology was assessed by an
ophthalmologist trained in GDx analysis.
STATISTICAL ANALYSIS
Analyses were performed using NCSS – Statistical and Power
Analysis Software 2007 and STAT. Differences across all groups
were assessed using ANOVA tests, which were applied for the
determination of differences between the data of the patient and
control groups. The relationship between healthy and MS eyes
was examined by Mann–Whitney test, separately for both ON and
NON-groups. Spearman correlation analysis was used to deter-
mine the relationship of MRI measures with VEP parameters,
RNFL thickness, EDSS, and disease duration. Statistical meth-
ods were consulted with Peter Slezak from Bio-Med-Stat Cen-
ter (Faculty of Mathematics, Physics, and Informatics, Comenius
University in Bratislava).
RESULTS
In the ON group, both brain atrophy and MRI brain new lesions
correlated with lower VEP amplitudes. This correlation was found
only in the right eye. We did not find any significant association
of VEP latency and brain atrophy or new brain lesions in MRI.
Both disease duration and age of patients significantly correlated
with brain atrophy measures, but we did not find this relationship
with new MRI brain lesions. EDSS score was also related to brain
atrophy but not to new MRI brain lesions. The results are shown
in Table 2A.
In patients without a history of ON (NON), VEP parameters
showed even stronger association with both MRI new brain lesions
and brain atrophy than in ON group. We found a significant but
moderate relationship of new brain T2 lesions with longer laten-
cies of VEP in the left and right eyes. We also found correlation
of VEP amplitudes and MRI new brain lesions. VEP latency delay
correlated significantly with duration of disorder. EDSS values
correlated with brain atrophy and also mildly with MRI new brain
lesions. In this group, association of RNFL thickness and brain
atrophy was proved for the left eye. MRI brain atrophy correlated
with disease duration. Results are shown in Table 2B.
Multiple sclerosis patients from both groups did not differ
in many parameters such as age (p= 0.12), duration of disor-
der (p= 0.32), duration of treatment (p= 0.12), EDSS (p= 0.32),
VEP latency right (p= 0.3), VEP amplitude right (p= 0.67), VEP
amplitude left (p= 0.7), RNFL thickness right (p= 0.6) and left
(p= 0.3), and nerve fiber indicator (NFI) right (p= 0.97) and
NFI left (p= 0.3). The only difference found was in VEP latency
in left eyes (p= 0.01). This fact encouraged us to evaluate both
MS groups together.
Table 2 | (A) Correlation of MRI with age,VEP, RNFL, EDSS and disease
duration ON patients. (B) Correlation of MRI with age,VEP, RNFL,
EDSS and disease duration NON-patients.
(A)
ON patients (n=17) MRI brain new lesions MRI brain atrophy
Age (years) ns r =0.3, p=0.09
VEP lat right (ms) ns ns
VEP ampl right (µV) r =−0.8, p=0.0002 r =−0.15, p=0.07
VEP lat left (ms) ns ns
VEP ampl left (µV) ns ns
RNFL right (µm) ns ns
RNFL left (µm) ns ns
EDSS (1–10) ns r =0.42, p=0.006
Disease duration (years) ns r =0.5, p=0.02
(B)
NON-patients (n=24) MRI brain new lesions MRI brain atrophy
Age (years) r =0.46, p=0.02 ns
VEP lat right r =0.36, p=0.08 r =0.63, p=0.001
VEP ampl right r =−0.3, p=0.09 r =−0.1, p=0.09
VEP lat left r =0.4, p=0.03 r =0.6, p=0.01
VEP ampl left r =−0.42, p=0.04 r =−0.5, p=0.02
RNFL right ns ns
RNFL left ns r =−0.4, p=0.05
EDSS r =0.3, p=0.09 r =0.5, p=0.01
Disease duration ns r =0.5, p=0.09
Spearman analysis (p = 0.05 statistical significance), ns = non-significant, MRI
brain atrophy = presence of brain atrophy, MRI brain new lesions =T2 hyperin-
tense new brain lesions, EDSS = expanded disability status scale.
Both brain atrophy and new MRI brain lesions have shown
stronger correlation with VEP results than with GDx RNFL
measures.
Brain atrophy correlated with VEP latencies of the right eyes of
the MS patients, but not of the left ones. A significant correlation
of VEP latencies and VEP amplitudes with new brain lesions in
MRI was found in right and left eyes. The results are described in
Tables 3A,B.
A relationship was observed in VEP latencies and EDSS scores
in right and left eyes. Amplitudes of VEP did not match with EDSS
(Table 4).
When compared with healthy controls, statistical analysis
showed reduction of RNFL measured by GDx of optic nerve MS
eyes. The results were supported by the measurement of NFI,
which serves as a comparator of normal and damaged peripapillary
nerve fibers. Higher levels of NFI indicate advanced impairment
of optic nerve fibers. NFI values of MS patients were higher and
significantly different from values of healthy controls. Results of
average RNFL thicknesses are shown in Table 5.
Despite the significant difference in GDx RNFL of MS and
healthy eyes, neither MRI brain atrophy nor new MRI brain lesions
correlated with GDx RNFL thickness and NFI in the MS group.
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GDx RNFL measures correlated with VEP latencies, but not
with VEP amplitudes. We did not confirm any association between
RNFL thickness and disease duration.
The results are in Table 6.
DISCUSSION
Many studies have shown the presence of alteration of the visual
system in MS as a possible method to test its subclinical progres-
sion (Sisto et al., 2005; Zaveri et al., 2008; Pueyo et al., 2010).
There are different opinions as to which examination is the most
Table 3 | (A) Correlation ofVEP latency and MRI brain atrophy, MRI
brain new lesions in all MS patients; (B) correlation ofVEP amplitudes
and MRI brain atrophy, MRI brain new lesions in all MS patients.
(A)
VEP lat right/MRI
correlation
VEP lat left/MRI
correlation
MRI atrophy r =0.63, p=0.01 ns
MRI brain new lesions r =0.6, p=0.02 r =0.6, p=0.03
(B)
VEP ampl right/MRI
correlation
VEP ampl left/MRI
correlation
MRI atrophy r =−0.4, p=0.03 r =−0.5, p=0.08
MRI brain new lesions r =−0.7, p=0.004 r =−0.6, p=0.01
Spearman correlation test (p=0.05 statistical significance). VEP lat= latency of
visual evoked potential, VEP ampl= amplitude of visual evoked potential, MRI
atrophy= presence of brain atrophy, MRI brain new lesions=T2 hyperintense
new brain lesions.
Table 4 | Correlation of EDSS andVEP latency andVEP amplitude in all
MS patients.
MS patients
(n=41)
VEP latency
right (ms)
VEP ampl
right (µV)
VEP latency
left (ms)
VEP ampl
left (µV)
EDSS r =0.8,
p<0.000
ns r =0.64,
p=0.007
ns
Spearman correlation test (p=0.05 statistical significance). VEP lat= latency of
visual evoked potential, VEP ampl= amplitude of visual evoked potential.
appropriate. In several studies, two or more tests were performed
on the same sample of patients to increase the overall sensitivity.
Only a few studies have reported MRI correlations with GDx and
VEP (Frohman et al., 2009).
In our study, VEP tests have been found to be more sensi-
tive than GDx. There was a reduction in VEP amplitude in a
group of patients with axonal damage (MRI brain atrophy) or
active conduction block due to focal demyelinization (new T2
brain lesions in MRI), while VEP latencies remained abnormal
in a group of patients with diffuse demyelinization and also with
extensive axonal damage (VEP P100 correlated with MRI new T2
lesion and brain atrophy).
Separate comparisons have revealed the VEP latency testing to
be less sensitive in ON than NON-patients in detecting axonal
damage. In ON patients, VEP amplitude was linked to brain atro-
phy and also to new MRI brain lesions, but only in the right eye of
subjects. We explain this by the fact that the residual axonal deficit
was more pronounced in the right than in the left eye. Axonal
degeneration seems to be non-equally implicated in optic nerves.
In ON group, recovery from optic neuritis was less prominent in
the right than in the left eye. On the other hand, positive VEP tests
in NON-group have confirmed capability of VEP to reveal silent
demyelinization and brain atrophy processes.
Magnetic resonance imaging was not aimed at detecting optic
nerve involvement, and we did not use specific orbital short T1
inversion recovery (STIR) sequences for optic nerve evaluation. In
that situation, MRI outcomes reflected intensive demyelinization
and axonal degeneration of brain without determination of pre-
and retrochiasmatic processes. Therefore, our results support the
importance of both methods,VEP and MRI, in disease progression
control.
Number of T2 lesions is considered to be a weak predictor of
disability in MS (Barkhof, 1999). In NON-group of our patients,
EDSS values mildly correlated with new brain MRI T2 lesions.
This association reflected activity of the disorder. At the time of
the examination, the patients were undergoing treatment by first
line immunomodulatory agents, but many of them were shifted
to another first line or second line medication in the following
12-month period (45% from NON-group). MRI is traditionally
used to monitor disease progression.
Some authors have also reported the important role of VEP
in the prediction of the disability progression (Trip et al., 2007;
Klistorner et al., 2011). Frederiksen et al. compared the sensitivity
of MRI and electrophysiological tests (VEP and somatosensory
evoked potential). The combination of these methods revealed
Table 5 | GDx RNFL in groups: ON, NON, and controls.
ON (n=17) CON (n=22) ON/CON NON (n=24) NON/CON
RNFL right (µm) 51.0±1.28 (m=52.0) 57.06±1.09 (m=57.6) p=0.0014 52.5±1.05 (m=52.5) p=0.002
RNFL left (µm) 50.5±1.36 (m=50.2) 56.6±1.19 (m=57.35) p=0.001 53.2±1.92 (m=52.0) p=0.015
NFI right (µm) 24.1±3.7 (m=18.5) 15.0±5.2 (m=14.5) p=0.005 24.3±1.4 (m=21.5) p=0.05
NFI left (µm) 23.8±2.9 (m=25.5) 15.1± 5.2 (m=13.5) p=0.0001 21.8±1.3 (m=21.0) p=0.001
Mann–Whitney test (p=0.05 statistical significance), MS=multiple sclerosis, ON=history of optic neuritis, NON=without history of optic neuritis, CON= controls,
RNFL= retinal nerve fiber layer, NFI=nerve fiber indicator.
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Table 6 | Correlation of RNFL withVEP and disease duration.
RNFL right (µm) RNFL left (µm)
VEP lat (ms) r =−0.86, p=0.001 r =−0.5, p=0.009
VEP ampl (µV) ns ns
Disease duration (years) ns ns
Spearman correlation test (p=0.05 statistical significance), RNFL= retinal nerve
fiber layer, VEP= visual evoked potential, ns=non-significant.
abnormalities in 63% of the patients, but only monosymptomatic
subacute optic neuritis patients were tested. In this 1-year follow-
up study, the mean latency of VEP in patients with optic neuritis
was longer in clinically definite MS patients (Fredericsen et al.,
1991).
The strong correlation of cerebrospinal fluid oligoclonal bands
with VEP and multifocal MRI (p< 0.0000) in patients following
optic neuritis reflects the activity of the demyelinization processes,
as it was found by Horwitz et al. The authors proposed performing
VEP and MRI examinations before deciding on a lumbar punc-
ture,due to the high predictive role of both methods. Their patients
who had normal VEP and MRI findings had a 96% probability of
oligoclonal bands – negative cerebrospinal fluid values obtained
by lumbar puncture samples (Horwitz et al., 2012).
Based on VEP, MRI, perimetry, and contrast sensitivity tests,
Sisto et al. reported a large prevalence of visual pathway involve-
ment in patients affected by MS with no history of optic neuritis
and no visual symptoms. Despite low specificity, the tests were
sensitive enough to reflect inflammation and subsequent degen-
eration of CNS, even in patients without history of optic neuritis.
The usefulness of the combination of multiple examinations in
the detection of nearly all cases of visual pathway involvement was
emphasized (Sisto et al., 2005).
In our work, the predictive prognostic value of VEP has been
proved by positive association of VEP latencies and EDSS in ON
and NON MS patients.
Other reported data suggest that VEP and multimodal evoked
potentials may be more sensitive than clinical and MRI measures
in detecting disease evolution. Transversal and longitudinal studies
by Leocani demonstrated good correlation between evoked poten-
tials abnormalities and disability. Multimodal evoked potentials
abnormality score correlated significantly with EDSS and MRI in
transversal evaluation (Leocani et al., 2000).
We found a significant thinning of the nerve fiber layer in the
retina in all patients treated for MS, compared with healthy volun-
teers. Other authors found similar results (Della Mea et al., 2007;
Pueyo et al., 2008, 2010; Zaveri et al., 2008).
Our study did not find a significant correlation of GDx mea-
sures and MRI tests, except for a mild association of RNFL
thickness of the left NON-eye with MRI brain atrophy. The GDx
method was not able to detect whole brain demyelinization and
degeneration processes, but revealed only the involvement of optic
nerves in ON and NON-patients.
Advanced MRI techniques can provide explicit informa-
tion; some studies have documented their sensitivity (Sipman
et al., 2010). Frohman et al. compared non-conventional MRI
techniques (magnetization transfer ratio and diffusion tensor
imaging) with OCT and GDx VCC parameters. They found that
the association of OCT-measured RNFL thickness with brain MRI
measures was stronger than with GDx-measured RNFL thickness
(Frohman et al., 2009). Zimmermann et al. (2012) referred to
OCT RNFL as a parameter of neuro-axonal damage comparably
linked to white and gray matter atrophy. A significant correla-
tion between magnetization transfer ratio (MTR), measures of
axonal loss by OCT-RNFL thickness, and VEP amplitude was
referred by Trip et al. (2007). Whole-optic nerve MTR corre-
lated modestly with central-field VEP latency, but strongly with
lesion-only MTR measures. While latency delay correlated sig-
nificantly with MTR, correlation became non-significant when
adjusted for the degree of axonal loss (Trip et al., 2007; Klistorner
et al., 2011). The use of non-conventional MRI techniques in mon-
itoring patients in clinical practice is not widely advisable at the
moment. All these techniques still need to be evaluated for sen-
sitivity and specificity in detecting tissue damage in MS and its
changes over time (Filippi et al., 2011). Conventional MRI is a
widely available diagnostic tool in clinical practice. Our findings
highlight the usefulness of conventional MRI in the evaluation
of MS progression. MRI may still be a good biomarker for MS
evolution.
In our MS patients, RNFL measures correlated with VEP
latencies but not with VEP amplitudes.
The association of prolonged VEP latencies with RNFL thin-
ning was also shown by Pueyo et al. (2008). Other authors have
found a correlation of VEP amplitudes with RNFL thinning, or
no relationship, but only under OCT results (Parisi et al., 1999).
Naismith et al. considered VEP to be relatively more sensitive than
OCT in detecting cases with mild to moderate visual deficit. They
provided results of a retrospective study with 65 subjects with
systematical evaluation of OCT and VEP in MS patients with
history of optic neuritis ≥6 months prior to enrollment. They
found that OCT identified RNFL thinning in 60% of eyes with
previous ON, and in about 20% of subclinically affected eyes.
Positive results of VEP were detected in 81% (Naismith et al.,
2009). Pueyo et al. (2010) showed that GDx can be as accu-
rate as OCT and their measurement significantly correlated with
VEP P100 latencies. Correlations of GDx and VEP results were
described by Della Mea et al. (2007). They found standard auto-
mated perimetry and VEP to be more sensitive to axonal defects
in RNFL than GDx in MS. In contrast, a prospective study of
patients with MS showed GDx to be superior to functional oph-
thalmological and neurophysiological tests (Garcia-Martin et al.,
2010).
CONCLUSION
In our study, we found that both VEP and GDx can be used
as supplementary methods in detection of optic nerve dam-
age. We confirmed the superiority of VEP over GDx in eval-
uating whole brain demyelinization and axonal degeneration.
Both VEP and MRI, but not GDx, have an important role in
monitoring disease progression in MS patients, independently
of the ON history. The importance of VEP was supported
by its significant correlation with MRI measures and EDSS
values.
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